FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280490004> ?p ?o ?g. }

• W4280490004 abstract "To explore the prognostic significance of the stage at which a minimal residual disease (MRD)-negative status is achieved for patients with newly diagnosed multiple myeloma (NDMM) who received autologous hematopoietic stem cell transplantation (ASCT).A retrospective analysis of 186 NDMM patients who received induction therapy-ASCT-maintenance therapy in our center and achieved an MRD-negative status was performed. Patients were divided into three groups, A (induction therapy), B (3 months after ASCT), and C (maintenance therapy), according to the stage at which an MRD-negative status was achieved.The median time to progression (TTP) of 186 patients was not reached; the median overall survival (OS) was 113.8 months. The median TTP of the patients in three groups was not reached (P=0.013), and the median OS of the patients in three groups was not reached, not reached, and 71.2 months, respectively (P=0.026). Among patients with standard-risk cytogenetics, the median TTP of those in all three groups was not reached (P=0.121), and the median OS of the patients in three groups was not reached, not reached, and 99.6 months, respectively (P=0.091). Among patients with high-risk cytogenetics, the median TTP of those in three groups was not reached, 53.9 months, and 35.8 months (P=0.060), and the median OS was not reached, 71.2 months, and 60.2 months, respectively (P=0.625). Among patients with R-ISS stage I-II, the median TTP of those in three groups was not reached (P=0.174), and the median OS of the patients in three groups was not reached, not reached, and 99.6 months, respectively (P=0.186). Among the 29 patients with R-ISS stage III, the median TTP of those in the 3 groups were unreached, unreached, and 35.1 months (P<0.001), and the median OS was unreached, unreached, and 48.5 months, respectively (P=0.020). In all enrolled patients, the stage of reaching MRD-negative was an independent prognostic factor for TTP, rather than a prognostic factor for OS. The stage of reaching MRD-negative in patients with R-ISS III was an independent prognostic factor for OS.For the same patients who are MRD-negative, the prognoses of those who achieve an MRD-negative status at different groups are different. The stage at which an MRD-negative status is achieved can predict the prognosis of patients with R-ISS stage III." @default.
• W4280490004 created "2022-05-22" @default.
• W4280490004 creator A5017165240 @default.
• W4280490004 creator A5034882363 @default.
• W4280490004 creator A5036587437 @default.
• W4280490004 creator A5064711465 @default.
• W4280490004 creator A5067518142 @default.
• W4280490004 creator A5070695035 @default.
• W4280490004 creator A5079098564 @default.
• W4280490004 date "2022-05-18" @default.
• W4280490004 modified "2023-09-25" @default.
• W4280490004 title "Prognostic Significance of the Stage at Which an MRD-Negative Status Is Achieved for Patients With Multiple Myeloma Who Received ASCT" @default.
• W4280490004 cites W1981447363 @default.
• W4280490004 cites W2003920534 @default.
• W4280490004 cites W2028286166 @default.
• W4280490004 cites W2048954647 @default.
• W4280490004 cites W2071780943 @default.
• W4280490004 cites W2128192762 @default.
• W4280490004 cites W2139260559 @default.
• W4280490004 cites W2148758597 @default.
• W4280490004 cites W2486629951 @default.
• W4280490004 cites W2512081093 @default.
• W4280490004 cites W2518827451 @default.
• W4280490004 cites W2521738172 @default.
• W4280490004 cites W2883118036 @default.
• W4280490004 cites W2888510276 @default.
• W4280490004 cites W2893245372 @default.
• W4280490004 cites W2914023002 @default.
• W4280490004 cites W2947874495 @default.
• W4280490004 cites W2990816134 @default.
• W4280490004 cites W2991388489 @default.
• W4280490004 cites W3000488859 @default.
• W4280490004 cites W3003486931 @default.
• W4280490004 cites W3008027440 @default.
• W4280490004 cites W3011145723 @default.
• W4280490004 cites W3019889711 @default.
• W4280490004 cites W3045223998 @default.
• W4280490004 cites W3096986475 @default.
• W4280490004 cites W3112088296 @default.
• W4280490004 cites W3127779761 @default.
• W4280490004 doi "https://doi.org/10.3389/fonc.2022.776920" @default.
• W4280490004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35664799" @default.
• W4280490004 hasPublicationYear "2022" @default.
• W4280490004 type Work @default.
• W4280490004 citedByCount "0" @default.
• W4280490004 crossrefType "journal-article" @default.
• W4280490004 hasAuthorship W4280490004A5017165240 @default.
• W4280490004 hasAuthorship W4280490004A5034882363 @default.
• W4280490004 hasAuthorship W4280490004A5036587437 @default.
• W4280490004 hasAuthorship W4280490004A5064711465 @default.
• W4280490004 hasAuthorship W4280490004A5067518142 @default.
• W4280490004 hasAuthorship W4280490004A5070695035 @default.
• W4280490004 hasAuthorship W4280490004A5079098564 @default.
• W4280490004 hasBestOaLocation W42804900041 @default.
• W4280490004 hasConcept C126322002 @default.
• W4280490004 hasConcept C141071460 @default.
• W4280490004 hasConcept C143998085 @default.
• W4280490004 hasConcept C146357865 @default.
• W4280490004 hasConcept C151730666 @default.
• W4280490004 hasConcept C167135981 @default.
• W4280490004 hasConcept C2776364478 @default.
• W4280490004 hasConcept C2777408962 @default.
• W4280490004 hasConcept C2779050716 @default.
• W4280490004 hasConcept C2779709957 @default.
• W4280490004 hasConcept C2779823535 @default.
• W4280490004 hasConcept C2780007613 @default.
• W4280490004 hasConcept C2911091166 @default.
• W4280490004 hasConcept C3019894029 @default.
• W4280490004 hasConcept C65409693 @default.
• W4280490004 hasConcept C71924100 @default.
• W4280490004 hasConcept C86803240 @default.
• W4280490004 hasConcept C90924648 @default.
• W4280490004 hasConceptScore W4280490004C126322002 @default.
• W4280490004 hasConceptScore W4280490004C141071460 @default.
• W4280490004 hasConceptScore W4280490004C143998085 @default.
• W4280490004 hasConceptScore W4280490004C146357865 @default.
• W4280490004 hasConceptScore W4280490004C151730666 @default.
• W4280490004 hasConceptScore W4280490004C167135981 @default.
• W4280490004 hasConceptScore W4280490004C2776364478 @default.
• W4280490004 hasConceptScore W4280490004C2777408962 @default.
• W4280490004 hasConceptScore W4280490004C2779050716 @default.
• W4280490004 hasConceptScore W4280490004C2779709957 @default.
• W4280490004 hasConceptScore W4280490004C2779823535 @default.
• W4280490004 hasConceptScore W4280490004C2780007613 @default.
• W4280490004 hasConceptScore W4280490004C2911091166 @default.
• W4280490004 hasConceptScore W4280490004C3019894029 @default.
• W4280490004 hasConceptScore W4280490004C65409693 @default.
• W4280490004 hasConceptScore W4280490004C71924100 @default.
• W4280490004 hasConceptScore W4280490004C86803240 @default.
• W4280490004 hasConceptScore W4280490004C90924648 @default.
• W4280490004 hasFunder F4320321001 @default.
• W4280490004 hasFunder F4320321160 @default.
• W4280490004 hasFunder F4320321921 @default.
• W4280490004 hasLocation W42804900041 @default.
• W4280490004 hasLocation W42804900042 @default.
• W4280490004 hasLocation W42804900043 @default.
• W4280490004 hasLocation W42804900044 @default.
• W4280490004 hasOpenAccess W4280490004 @default.
• W4280490004 hasPrimaryLocation W42804900041 @default.
• W4280490004 hasRelatedWork W2039217067 @default.

• next